Agilon Health (NYSE:AGL) Hits New 12-Month High Following Analyst Upgrade

Agilon Health, Inc. (NYSE:AGL)’s share price hit a new 52-week high during trading on Wednesday after Barclays upgraded the stock from an underweight rating to an equal weight rating. Barclays now has a $81.00 price target on the stock. Agilon Health traded as high as $91.85 and last traded at $90.87, with a volume of 241283 shares. The stock had previously closed at $85.27.

A number of other analysts have also weighed in on AGL. Robert W. Baird increased their target price on Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Weiss Ratings raised shares of Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 12th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $72.00 price target (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. Benchmark reissued a “buy” rating and issued a $95.00 price objective (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Finally, Citigroup restated a “neutral” rating and issued a $80.00 target price (up from $18.75) on shares of Agilon Health in a research note on Friday, May 15th. Five research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Agilon Health presently has a consensus rating of “Hold” and an average target price of $58.73.

Institutional Trading of Agilon Health

Institutional investors and hedge funds have recently made changes to their positions in the company. Goldman Sachs Group Inc. grew its holdings in Agilon Health by 196.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after acquiring an additional 13,283,930 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Agilon Health by 1,346.6% in the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the period. CenterBook Partners LP lifted its position in shares of Agilon Health by 492.4% in the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares during the period. North Peak Capital Management LLC boosted its stake in shares of Agilon Health by 10.8% during the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after purchasing an additional 3,715,460 shares in the last quarter. Finally, Voleon Capital Management LP increased its holdings in Agilon Health by 5,519.2% during the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after buying an additional 2,692,259 shares during the period.

Agilon Health Trading Up 6.5%

The company has a market capitalization of $1.52 billion, a PE ratio of -4.21 and a beta of 2.29. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The company’s fifty day moving average is $35.01 and its 200-day moving average is $23.33.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. On average, analysts anticipate that Agilon Health, Inc. will post -3.75 EPS for the current fiscal year.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.